FDA warns German outfit over needle manufacturing quality; Harvard team tests computer tablet neuromuscular Dx device;

 @FierceMedDev: True Diagnostics revs up EU prostate cancer Dx launch. Story | Follow @FierceMedDev

 @MarkHFierce: Minnesota's legislative delegation is pursuing a new repeal effort for the 2.3% medical device tax. News | Follow @MarkHFierce

 @DamianFierce: A new brain-stimulation method could make a major difference for depression sufferers, according to a study. More | Follow @DamianFierce

> The FDA warned Germany's FSSB Chirurgische Nadeln GMBH over quality system manufacturing violations at a plant that manufactures sterile and non-sterile needles and sutures. Item

> Cardiva Medical gained premarket approval for its new Vascade vascular closure system, thank, in part to positive data from a 420-patient trial. Release

> UltraSounds Medical Devices, a Michigan startup, raised more than $1.4 million in new financing from an undisclosed investor. Item

> MedCity News reports on 5 innovative medical device-related uses for infrared technology. Story

> Researchers at Harvard University, Beth Israel Deaconess Medical Center and elsewhere successfully tested a new computer tablet application designed to rapidly assess neuromuscular function at the bedside. Release

> Germany's federal healthcare reimbursement program signed off on Delcath System's Chemostat, a liver cancer drug delivery system for chemotherapy that won a CE mark in 2012. Story

> Scientists are testing the use of nanoparticles, in part, to boost the performance of medical CT scanners. Story

Biotech News

 @FierceBiotech: From FierceBiotechIT.com: Biotech, pharma warming up to Facebook. Article | Follow @FierceBiotech

@JohnCFierce: 7 pharmas join hands to create a new discovery platform--€196M: Report | Follow @JohnCFierce

@RyanMFierce: The Swiss biotech Addex is downsizing its Geneva operation after cuts last year. No details on jobs. Release | Follow @RyanMFierce

> Elan fails to inspire analysts with deal-making plans for $3.25B. Report

> Ticktock: Lilly scraps RA program as another PhIII drug disappoints. News

Pharma News

@FiercePharma: Here's one way for pharma to boost earnings: Cut tax rates. Story | Follow @FiercePharma

@EricPFierce: Would your plant receive an A or an F under FDA Woodcock's suggestion of letter grades for quality? More from FiercePharmaManufacturing | Follow @EricPFierce

@AlisonBFierce: GBI Research forecasts that the global pediatric vaccines market will hit $24.3 billion by 2017. More | Follow @AlisonBFierce

> Teva hikes dividend as earnings fall short. News

> Swamped with generics, Sanofi rides Lantus to dry land. Article

> Fight for anticoagulant market heats up with antidote deals. More

Pharma Manufacturing News

> Specialized manufacturing technology punches ticket to Protalix's value. Report

> China sends 7 to prison for producing toxic capsules. Story

> Meds from foreign plants complicate counterfeit search. More

> GSK to squeeze manufacturing in Europe but U.K. spared. Article

Vaccines News

> Global health funding slows amid financial concerns. Report

> Parents supportive of vaccinating boys for HPV. Item

> Gates-backed researchers explore pain-free vaccine technology. Article

> Merck, GSK partner with GAVI to provide low-cost HPV vaccine. News

> Despite setback, TB vaccine study is a step in the right direction. More

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.